Trial intelligence / Profile preview

Standardization and safety study of external Jiu Yi Powder therapy

ChiCTR-TNC-11001366Phase 4Completed

Sponsor
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Start
Jan 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of jiu yi powder in Plasma cell mastitis (PCM), Not applicable, anal fistula and 1 more, sponsored by Longhua Hospital Shanghai University of Traditional Chinese Medicine. Primary endpoints: Urine mercury and Blood mercury. Started Jan 2009; status: completed.

02

Drugs

jiu yi powder
03

Conditions

Plasma cell mastitis (PCM)Not applicableanal fistulaleg ulcer

Beyond the preview

Go deeper on ChiCTR-TNC-11001366.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TNC-11001366.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call